Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism
Vito Angelo Giagulli, Maria D. Carbone, Maria Isabella Ramunni, et al.
Andrology (2015) Vol. 3, Iss. 6, pp. 1094-1103
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Erectile dysfunction and diabetes: A melting pot of circumstances and treatments
Giuseppe Defeudis, Rossella Mazzilli, Marta Tenuta, et al.
Diabetes/Metabolism Research and Reviews (2021) Vol. 38, Iss. 2
Open Access | Times Cited: 162
Metabolic Disorders and Male Hypogonadotropic Hypogonadism
Rosario Pivonello, Davide Menafra, Enrico Riccio, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 109
Liraglutide Ameliorates Erectile Dysfunction via Regulating Oxidative Stress, the RhoA/ROCK Pathway and Autophagy in Diabetes Mellitus
Penghui Yuan, Delin Ma, Xintao Gao, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 75
Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism
Valentina Annamaria Genchi, Erica Rossi, Celeste Lauriola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8194-8194
Open Access | Times Cited: 65
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health
M. Alemany
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11952-11952
Open Access | Times Cited: 57
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age
Giuseppe Lisco, Olga Disoteo, Anna De Tullio, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 63-63
Open Access | Times Cited: 31
Male hypogonadism is associated with obesity
P. Ya. Merzlova, С. В. Булгакова, D. P. Kurmaev, et al.
Experimental and Clinical Gastroenterology (2025), Iss. 8, pp. 65-75
Closed Access | Times Cited: 1
Modifying Risk Factors in the Management of Erectile Dysfunction: A Review
Kenneth J. DeLay, Nora M. Haney, Wayne J.G. Hellstrom
The World Journal of Men s Health (2016) Vol. 34, Iss. 2, pp. 89-89
Open Access | Times Cited: 80
Klinefelter syndrome: cardiovascular abnormalities and metabolic disorders
Aldo E. Calogero, Vito Angelo Giagulli, Laura M. Mongioì, et al.
Journal of Endocrinological Investigation (2017) Vol. 40, Iss. 7, pp. 705-712
Closed Access | Times Cited: 79
Effects of liraglutide on obesity-associated functional hypogonadism in men
Mojca Jensterle, Ana Podbregar, Katja Goričar, et al.
Endocrine Connections (2019) Vol. 8, Iss. 3, pp. 195-202
Open Access | Times Cited: 65
Obesity and Erectile Dysfunction: From Bench to Clinical Implication
Ki Hak Moon, So‐Young Park, Yong-Woon Kim
The World Journal of Men s Health (2018) Vol. 37, Iss. 2, pp. 138-138
Open Access | Times Cited: 61
Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men’s Health?
Dimitri Yannas, Francesca Frizza, Linda Vignozzi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 10, pp. 2221-2221
Open Access | Times Cited: 43
Sexual and Reproductive Outcomes in Obese Fertile Men with Functional Hypogonadism after Treatment with Liraglutide: Preliminary Results
Sandro La Vignera, Rosita A. Condorelli, Aldo E. Calogero, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 672-672
Open Access | Times Cited: 22
The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease
Abdulmaged M. Traish, Michael Zitzmann
Reviews in Endocrine and Metabolic Disorders (2015) Vol. 16, Iss. 3, pp. 249-268
Closed Access | Times Cited: 50
Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives
Andrea Salzano, Roberta D’Assante, Liam M. Heaney, et al.
Endocrine (2018) Vol. 61, Iss. 2, pp. 194-203
Open Access | Times Cited: 47
Weight loss more than glycemic control may improve testosterone in obese type 2 diabetes mellitus men with hypogonadism
Vito Angelo Giagulli, Marco Castellana, Matteo Domenico Carbone, et al.
Andrology (2020) Vol. 8, Iss. 3, pp. 654-662
Open Access | Times Cited: 42
Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study
Farid Saad, Gheorghe Doros, Karim Sultan Haider, et al.
International Journal of Obesity (2020) Vol. 44, Iss. 6, pp. 1264-1278
Open Access | Times Cited: 40
Sexual Dysfunction in Men and Women with Diabetes: A Reflection of their Complications?
Andrea Sansone, Daniele Mollaioli, Giacomo Ciocca, et al.
Current Diabetes Reviews (2021) Vol. 18, Iss. 1
Closed Access | Times Cited: 35
Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis
Shorouk A. Alafifi, Sara A. Wahdan, Alzahraa A. Elhemiely, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 11, pp. 2987-3005
Open Access | Times Cited: 16
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial
Harpreet S. Bajaj, Hertzel C. Gerstein, Rao Ps, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 8, pp. 484-490
Closed Access | Times Cited: 30
Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities
Shiying Shao, Xiaoling Zhang, Qinqin Xu, et al.
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108270-108270
Closed Access | Times Cited: 21
Effects of diet and antihyperglycemic drugs on erectile dysfunction: A systematic review
Giuseppe Defeudis, Rossella Mazzilli, Alfonso Maria Di Tommaso, et al.
Andrology (2022) Vol. 11, Iss. 2, pp. 282-294
Open Access | Times Cited: 20
Effects of Anti-Diabetic Drugs on Erectile Dysfunction: A Systematic Review and Meta-Analysis
Bo Yang, Hui-Yun Cheng, Yu‐Feng Hu, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 467-478
Open Access
Effects of glucagon‐like peptide 1 receptor agonists on testicular dysfunction: A systematic review and meta‐analysis
Gianmaria Salvio, Alessandro Ciarloni, Nicola Ambo, et al.
Andrology (2025)
Open Access
Male sexual dysfunction associated with GLP-1 receptor agonists: a cross-sectional analysis of FAERS data
Ashkan Pourabhari Langroudi, Abby L. Chen, Satvir Basran, et al.
International Journal of Impotence Research (2025)
Closed Access
Page 1 - Next Page

Scroll to top